SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 12th, 2015 • Tapimmune Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 12th, 2015 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of January 12, 2015, is by and among TapImmune Inc., a Nevada corporation with offices located at 1551 Eastlake Avenue East, Suite 100, Seattle, Washington 98102 (the “Company”), and each of the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
OLYMPUS SECURITIES, LLCFinder's Fee Agreement • January 12th, 2015 • Tapimmune Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 12th, 2015 Company Industry Jurisdiction
STRICTLY CONFIDENTIALExclusive Agency Agreement • January 12th, 2015 • Tapimmune Inc • Pharmaceutical preparations • New York
Contract Type FiledJanuary 12th, 2015 Company Industry JurisdictionReference is made to the exclusive engagement letter (the “Engagement Letter”), dated July 29, 2014, by and between TapImmune Inc. (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which Wainwright shall serve as the exclusive investment bank of the Company during the “Term” (as defined in the Engagement Letter).